← Leaderboards
Kim L Brouwer
University Of North Carolina Chapel Hill
$15,343,248
Attributed
$21,000,679
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,000,679 · 11
By mechanism
T32$8,726,732 · 2
R01$6,466,680 · 1
R35$5,109,134 · 1
R56$365,043 · 1
R21$262,800 · 1
M01$43,150 · 4
Top collaborators
- Paul B Watkins16 shared
- Michael Cohen-Wolkowiez8 shared
- Daniel K Benjamin7 shared
- Daniel Gonzalez6 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Elizabeth Bullitt$8,051,616
- Henry Fuchs$2,021,720
- Min J Song$676,290
Others in their field
Top investigators on “Drug Interactions”
- Sharon A Nachman · Johns Hopkins University$209,857,565
- David Heimbrook · Leidos Biomedical Research, Inc.$173,156,929
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
Research focus
Drug InteractionsHepaticIn VitroPharmaceutical PreparationsLiverIn VivoClinical PharmacologyDrug TransportHepatocyteProgramsCarrier ProteinsPost-Doctoral TrainingTraining ProgramsBile AcidsExcretory FunctionProteinsResponseHepatobiliaryToxic EffectPlayClinical ResearchBiliaryPharmacotherapyFunding
Grant awards (64)
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$799,378
T32 · FY2025 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$607,396
R35 · FY2025 · GM · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$210,040
T32 · FY2025 · HD
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$607,595
R35 · FY2024 · GM · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$191,111
T32 · FY2024 · HD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$1
T32 · FY2024 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$744,336
T32 · FY2023 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$607,789
R35 · FY2023 · GM · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$185,119
T32 · FY2023 · HD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$710,612
T32 · FY2022 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$675,803
R35 · FY2022 · GM · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$192,030
T32 · FY2022 · HD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$706,465
T32 · FY2021 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$569,357
R35 · FY2021 · GM · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$184,040
T32 · FY2021 · HD
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$569,357
R35 · FY2020 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$550,453
T32 · FY2020 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement$86,400
T32 · FY2020 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$737,877
T32 · FY2019 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$569,357
R35 · FY2019 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$696,677
T32 · FY2018 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$569,357
R35 · FY2018 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$34,978
R35 · FY2018 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$624,326
T32 · FY2017 · GM · contact PI
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy$298,145
R35 · FY2017 · GM · contact PI
Altered Hepatic Disposition of Anionic Drugs-Mechanisms$585,275
R01 · FY2016 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$446,978
T32 · FY2016 · GM · contact PI
2016 Drug Metabolism Gordon Research Conference$27,140
R13 · FY2016 · TR · contact PI
Altered Hepatic Disposition of Anionic Drugs-Mechanisms$587,047
R01 · FY2015 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$272,007
T32 · FY2015 · GM · contact PI
Altered Hepatic Disposition of Anionic Drugs-Mechanisms$613,833
R01 · FY2014 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$399,970
T32 · FY2014 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$534,184
R01 · FY2013 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$389,699
T32 · FY2013 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$560,606
R01 · FY2012 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$382,402
T32 · FY2012 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$361,002
R01 · FY2011 · GM · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$216,811
T32 · FY2011 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$170,623
R01 · FY2011 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$364,804
R01 · FY2010 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$365,043
R56 · FY2009 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$354,451
R01 · FY2008 · GM · contact PI
CLINICAL TRIAL: MODULATION OF TECHNETIUM-99M MEBROFENIN HEPATIC TRANSPORT TO RIT$5,280
M01 · FY2008 · RR · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$308,798
R01 · FY2007 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$44,494
R01 · FY2007 · GM · contact PI
MODULATION OF TECHNETIUM-99M MEBROFENIN HEPATIC TRANSPORT TO RITONAVIR$12,568
M01 · FY2007 · RR · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$318,021
R01 · FY2006 · GM · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$23,760
R01 · FY2006 · GM · contact PI
QUANT OF TC-99M SESTAMIBI BILIARY EXCRETION IN HUMANS USING OROENTERIC CATHETER$10,160
M01 · FY2006 · RR · contact PI
VALIDATION OF A METHOD TO QUANTITATE BILIARY EXCRETION IN HUMANS$2,726
M01 · FY2006 · RR · contact PI
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$321,534
R01 · FY2005 · GM
DEVELOPMENT OF A MODEL TO PREDICT DRUG HEPATOTOXICITY$131,400
R21 · FY2005 · CA
VALIDATION OF A METHOD TO QUANTITATE BILIARY EXCRETION IN HUMANS$5,341
M01 · FY2005 · RR
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$290,860
R01 · FY2004 · GM
DEVELOPMENT OF A MODEL TO PREDICT DRUG HEPATOTOXICITY$131,400
R21 · FY2004 · CA
Validation of a Method to Quantitate Biliary Excretion in Humans$7,075
M01 · FY2004 · RR
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$289,928
R01 · FY2003 · GM
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$247,713
R01 · FY2002 · GM
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$36,001
R01 · FY2002 · GM
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS-MECHANISMS$259,097
R01 · FY2001 · GM
ALTERED HEPATIC DISPOSITION OF ANIONIC DRUGS--MECHANISMS$194,649
R01 · FY2000 · GM
EPHEDRINE SULFATE THEN SIBUTRAMINE FOR WEIGHT LOSS IN OBESE$0
M01 · FY2000 · RR
EPHEDRINE SULFATE THEN SIBUTRAMINE FOR WEIGHT LOSS IN OBESE$0
M01 · FY2000 · RR
EPHEDRINE SULFATE THEN SIBUTRAMINE FOR WEIGHT LOSS IN OBESE$0
M01 · FY2000 · RR